Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46,239,275
-
Total 13F shares
-
13,444,839
-
Share change
-
-697,426
-
Total reported value
-
$109,243,080
-
Price per share
-
$8.19
-
Number of holders
-
60
-
Value change
-
-$6,040,297
-
Number of buys
-
18
-
Number of sells
-
48
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2022
As of 30 Jun 2022,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,444,839 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., Stonepine Capital Management, LLC, CREDIT SUISSE AG/, Harel Insurance Investments & Financial Services Ltd., GREAT POINT PARTNERS LLC, RTW INVESTMENTS, LP, Migdal Insurance & Financial Holdings Ltd., MILLENNIUM MANAGEMENT LLC, Wildcat Capital Management, LLC, and Clal Insurance Enterprises Holdings Ltd.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.